2024-09-08 - Analysis Report
## DHR Stock Analysis

**Company Overview:** DHR, or Danaher Corporation, is a globally operating conglomerate focused on life science and diagnostics.

**Performance vs. S&P 500 (VOO):**
* **Cumulative Return (DHR):** 129.09%
* **Cumulative Return (VOO):** 81.34%
* **Difference:** 47.75%
* **Relative Divergence:** 38.54% (This indicates that DHR has outperformed the S&P 500 by a margin that is greater than 38.54% of the historical difference between the two assets.)

**Recent Price Movement:**
* **Closing Price:** 266.2
* **5-day Moving Average:** 265.79
* **20-day Moving Average:** 268.05
* **60-day Moving Average:** 260.18

**Technical Indicators:**
* **RSI:** 43.23 (Neutral: The RSI is below 70, suggesting no overbought conditions.)
* **PPO:** -0.35 (Neutral: The PPO is negative, suggesting a slightly bearish momentum.)
* **Delta_Previous_Relative_Divergence:** -4.55 (This indicates a short-term downtrend.)
* **Expected Return:** 76.16% (This represents the potential maximum return on investment over a 5-year period.)

**Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-23 | 1.23 | 5.74 B$ |
| 2024-04-23 | 1.47 | 5.80 B$ |
| 2024-02-21 | 1.46 | 6.41 B$ |
| 2023-10-24 | 1.53 | 5.62 B$ |
| 2024-02-21 | 1.53 | 5.62 B$ |

* **Most Recent Earnings:** The most recent earnings report, released on July 23, 2024, showed an EPS of 1.23 and revenue of 5.74 billion dollars. The EPS missed analysts' estimates of 1.32, while revenue slightly exceeded expectations.
* **Outlook:** Despite a slight miss in EPS, DHR's revenue growth continues to be steady. The company's focus on life science and diagnostics positions it well for continued growth in the long term.

**Overall Analysis:**
Danaher Corporation (DHR) has outperformed the S&P 500 significantly in the past, with a higher cumulative return. Although the current price action shows a slight downtrend, recent earnings and the company's position in the growing life science and diagnostics markets suggest potential for continued growth. The technical indicators currently signal a neutral market position, however, the expected return remains strong. This suggests that DHR might be a good long-term investment opportunity for investors seeking a balance between growth and stability. 
